@EricTopol @statnews @adamfeuerstein Small correction: 82% vs 70% is 2-year recurrence-free survival (vaccine arm higher), not mortality. No OS data yet. And the population is resected stage IIB–IV, not metastatic. The 42% RRR in recurrence is the headline. #ESMO26